Clinical Trial Update: Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating olanzapine as monotherapy for bipolar I depression has completed, reporting its efficacy as a standalone treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: China Medical University, China | Conditions: Bipolar Disorder, Depression, Bipolar | Phase 4 | Status: COMPLETED